STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy

Abstract As cancer continues to rank among the leading causes of death, the demand for novel treatments has never been higher. Immunotherapy shows promise, yet many solid tumors such as pancreatic cancer or glioblastoma remain resistant. In these, the “cold” tumor microenvironment with low immune ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Gehrcken, Christophe Deben, Evelien Smits, Jonas R.M. Van Audenaerde
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202500296
Tags: Add Tag
No Tags, Be the first to tag this record!